A coalition of employers, legislators, consumer advocates, health plans, and drug companies may bring about equal coverage
Martin Sipkoff
The goal is to keep oncologists from relying on drug markups to keep their incomes high, but it’s slow going
Lola Butcher
An experienced negotiator and lawyer describes in detail how health plans that contract with PBMs can get a better deal
Linda Cahn
The company can be expected to be as tough in the PBM arena as in retail, but it has a few hurdles to overcome
John Carroll
A national leader in physician quality improvement believes providers should be judged on the services they provide
The government program is a big — and still growing — business. Millions of members are being enrolled in managed care plans.
Tom Reinke
A system in which individual insurance policies may be purchased for separate medical products and services is based on a medical options market and takes its cue from the financial sector
Damon Douglas, dual PharmD/MBA candidate
Hard-charging New York Attorney General Andrew Cuomo says reported rates are neither usual nor customary, nor are they reasonable
Over-the-counter medications can be a good thing for the patient, the insurer, and the pharmaceutical company that developed the product
Hal Hoffman’s work led to the discovery of the genetic basis of an autosomal dominant disease and to creation of a prototypical orphan drug
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.
